Osteoporosis International

, Volume 22, Issue 12, pp 3079–3080 | Cite as

Re: The calcium scare: what would Austin Bradford Hill have thought?

Letter to the Editor


  1. 1.
    Nordin BE, Lewis JR, Daly RM et al. (2011) The calcium scare—what would Austin Bradford Hill have thought? Osteoporos Int. doi: 10.1007/s00198-011-1680-4
  2. 2.
    Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691PubMedCrossRefGoogle Scholar
  3. 3.
    Bolland MJ, Avenell A, Baron JA et al. (2010) Calcium and cardiovascular risk- author response. BMJ http://www.bmj.com/content/341/bmj.c3691/reply#bmj_el_240991. Accessed 5 Sept 2011
  4. 4.
    Bolland MJ, Avenell A, Baron JA et al. (2010) Calcium and cardiovascular risk- author response to further issues. BMJ http://www.bmj.com/content/341/bmj.c3691/reply#bmj_el_240994. Accessed 5 Sept 2011
  5. 5.
    Reid IR, Bolland MJ, Avenell A et al (2011) Cardiovascular effects of calcium supplementation. Osteoporos Int 22:1649–1658PubMedCrossRefGoogle Scholar
  6. 6.
    Bolland MJ, Barber PA, Doughty RN et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262–266PubMedCrossRefGoogle Scholar
  7. 7.
    Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300PubMedGoogle Scholar
  8. 8.
    Demer LL (1995) A skeleton in the atherosclerosis closet. Circulation 92:2029–2032PubMedGoogle Scholar
  9. 9.
    Ronni-Sivula H (1985) Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74:13–18PubMedGoogle Scholar
  10. 10.
    Palmer M, Adami HO, Bergstrom R et al (1987) Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet 1:59–62PubMedCrossRefGoogle Scholar
  11. 11.
    Hedback G, Oden A (1998) Increased risk of death from primary hyperparathyroidism—an update. Eur J Clin Invest 28:271–276PubMedCrossRefGoogle Scholar
  12. 12.
    Lundgren E, Lind L, Palmer M et al (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 130:978–985PubMedCrossRefGoogle Scholar
  13. 13.
    Nilsson IL, Yin L, Lundgren E et al (2002) Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17(Suppl 2):N68–N74PubMedGoogle Scholar
  14. 14.
    Vestergaard P, Mollerup CL, Frokjaer VG et al (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27:216–222PubMedCrossRefGoogle Scholar
  15. 15.
    Ogard CG, Engholm G, Almdal TP et al (2004) Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977–1993 in Denmark. World J Surg 28:108–111PubMedCrossRefGoogle Scholar
  16. 16.
    Bolland MJ, Grey A, Reid IR (2011) Calcium supplements and cardiovascular risk. J Bone Miner Res 26:899PubMedCrossRefGoogle Scholar
  17. 17.
    Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040PubMedCrossRefGoogle Scholar
  18. 18.
    Tang BMP, Eslick GD, Nowson C et al (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370:657–666PubMedCrossRefGoogle Scholar
  19. 19.
    DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463CrossRefGoogle Scholar
  20. 20.
    Reid IR, Bolland MJ, Grey A (2008) Effect of calcium supplementation on hip fractures. Osteoporos Int 19:1119–1123PubMedCrossRefGoogle Scholar
  21. 21.
    Grant AM, Avenell A, Campbell MK et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621–1628PubMedCrossRefGoogle Scholar
  22. 22.
    Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683PubMedCrossRefGoogle Scholar
  23. 23.
    Prince RL, Devine A, Dhaliwal SS et al (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166:869–875PubMedCrossRefGoogle Scholar
  24. 24.
    Reid IR, Mason B, Horne A et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119:777–785PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2011

Authors and Affiliations

  1. 1.Department of MedicineUniversity of AucklandAucklandNew Zealand
  2. 2.Bone and Joint Research Group, Department of MedicineUniversity of AucklandAucklandNew Zealand

Personalised recommendations